Links

Administrative simplicity vs. single payer. 340B case heads to the Supreme Court. Marketing and mammograms NY ends state of emergency: what happens to out-of-state licensed health care professionals? Key facts on the Delta Variant.

Links

Evaluating the robustness of CMS Hospital VBP measurement system. ICER’s gene therapy evaluations. Who are high-frequency hospital users? EHR and malpractice. What is Evio? Has in vivo gene editing come of age?

Links

Why the FDA approved aducanumab.  How to report changes in clinical trial protocols due to COVID-19 (CONSERVE) Democrats eye Medicare and Medicaid expansions. ACA and biosimilars. The challenges of improving quality of care. Native Americans and health equity.

Links

Physician compensation during the pandemic. Caring for an aging nation. The debt snowball. Infection rate among the unvaccinated is as high as it was back in January CMS all-in on mandatory pay-for-performance reimbursement. Patients minimize cost by reducing Q, not trying to minimize P.

Links

Affordability vs. Innovation. “standardizing contracts generates larger savings with less variance than savings from single‐payer strategies” The placebo effect examined Income growth in knowledge industries. Alcohol sales restrictions and alcohol poisoning mortality.

Links

LGBTQ Economics. Does health insurance improve health outcomes for cancer patients? Shattered. Mr. Jim. KHN: “Moderna…announced in October that it would not enforce its covid-related patents during the pandemic. Even so, no known independent producer has used the available patents to replicate the company’s mRNA vaccine. Experts say that’s telling.”

Links

Disability and distress. COVID-19 vaccine showdown: California vs. Texas. Opioid trajectories. “beliefs…are insufficiently skeptical about nondisclosed information in the absence of repeated feedback” What is ARPA-H?